Form 4 Tracker
Keenova Therapeutics plc
NONE

23 insider filings · Latest: Apr 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 17, 2026Apr 17 9:23 PMSilver Point Capital L.P.10% Owner
Purchase
410,000$90.50$37.1M5,637,714(D)

View →

Apr 15, 2026Apr 17 9:23 PMSilver Point Capital L.P.10% Owner
Purchase
275,000$88.50$24.3M5,227,714(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 23, 2026Feb 26 1:45 AMPaul BisaroDirector
Grant/Award
3,98447,225(D)

View →

← Previous

Page 2 of 2